Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume 47, Issue 11, Pages 1196-1205
Publisher
Wiley
Online
2016-12-22
DOI
10.1111/hepr.12854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Report of the 19th follow-up survey of primary liver cancer in Japan
- (2016) Masatoshi Kudo et al. HEPATOLOGY RESEARCH
- Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer
- (2016) Shih-Chieh Lin et al. Nature Communications
- Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice
- (2015) Takashi Kizu et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions
- (2015) Makoto Chuma et al. HEPATOLOGY RESEARCH
- Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features
- (2015) Dragana Kopanja et al. JOURNAL OF HEPATOLOGY
- FOXM1 is a therapeutic target for high-risk multiple myeloma
- (2015) C Gu et al. LEUKEMIA
- Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma
- (2015) Min Yu et al. TUMOR BIOLOGY
- Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia
- (2015) Maike Buchner et al. Nature Communications
- FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors
- (2015) Franziska Briest et al. Oncotarget
- FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
- (2015) Wen-Tai Chiu et al. Oncotarget
- Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells
- (2013) Haiyang Chen et al. CANCER LETTERS
- Foxm1 Expression in Prostate Epithelial Cells Is Essential for Prostate Carcinogenesis
- (2013) Yuqi Cai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
- (2012) Kaoru Okada et al. ANNALS OF SURGICAL ONCOLOGY
- Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma
- (2012) Limin Xia et al. JOURNAL OF HEPATOLOGY
- DLK1 as a Potential Target against Cancer Stem/Progenitor Cells of Hepatocellular Carcinoma
- (2012) X. Xu et al. MOLECULAR CANCER THERAPEUTICS
- FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria
- (2011) Hongcheng Sun et al. CANCER LETTERS
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Multiple faces of FoxM1 transcription factor
- (2011) Tanya V. Kalin et al. CELL CYCLE
- Loco-regional treatment of hepatocellular carcinoma
- (2010) Riccardo Lencioni HEPATOLOGY
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- FoxM1is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent onp27kip1
- (2009) Jiping Zeng et al. JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started